title: Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: effect of time of presentation.
abstract: Acute myocardial infarction (AMI) is associated with a stimulation of cortisol which lasts 24 hours in patients treated by thrombolysis. Percutaneous transluminal coronary angioplasty (PTCA) is an alternative treatment for AMI which reduces the length of myocardial ischemia. Our objective was the determination of the amplitude and duration of cortisol and other hormones of the hypothalamo-pituitary-adrenal (HPA) axis release in patients undergoing PTCA. These responses were also analyzed in relation with the time of onset of AMI. The effect of coronarography with or without angioplasty in patients without AMI was also studied. Plasma ACTH, cortisol, corticotropin-releasing hormone and arginine vasopressin levels were determined during the first 48 hours in 20 patients with first AMI, treated by PTCA and in 10 patients without AMI undergoing coronarography (and angioplasty in five of them). A strong stimulation of the HPA axis was observed in AMI patients, but the duration of cortisol secretion was significantly reduced (less than 8 hours) as compared with previous studies in patients treated with thrombolysis. A clear-cut ACTH-cortisol dissociation was also observed after the third hour. ACTH and cortisol stimulation was higher in patients admitted between 04:00 h and 16:00 h than in patients admitted between 16:00 h and 04:00 h In patients without AMI, coronarography induced a moderate, but significant short-lasting ACTH and cortisol stimulation. In conclusion, our data suggest that the degree of stimulation of the HPA axis may depend upon the type of treatment and the circadian rhythm of this axis.
authors.affiliation: Department of Cardiology, Assistance Publique Hôpitaux de Marseille, Institut Fédératif Jean Roche, School of Medicine, Université de la Méditerranée, Marseille, France.
authors.forename: F
authors.initials: F
authors.lastname: Paganelli
authors.forename: C
authors.initials: C
authors.lastname: Frachebois
authors.forename: J G
authors.initials: JG
authors.lastname: Velut
authors.forename: S
authors.initials: S
authors.lastname: Boullu
authors.forename: N
authors.initials: N
authors.lastname: Sauze
authors.forename: J P
authors.initials: JP
authors.lastname: Rosso
authors.forename: P
authors.initials: P
authors.lastname: Barnay
authors.forename: P
authors.initials: P
authors.lastname: Sbragia
authors.forename: R
authors.initials: R
authors.lastname: Gelisse
authors.forename: M
authors.initials: M
authors.lastname: Grino
authors.forename: S
authors.initials: S
authors.lastname: Levy
authors.forename: C
authors.initials: C
authors.lastname: Oliver
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001127:Arginine Vasopressin / Q000097:blood; D002940:Circadian Rhythm; D003346:Corticotropin-Releasing Hormone / Q000097:blood; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D010913:Pituitary-Adrenal System / Q000378:metabolism*; D015912:Thrombolytic Therapy; D013997:Time Factors
chemical_list: D001127:Arginine Vasopressin; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone